Avoidance and Period-Shortening of Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer in Stages I and II: Importance of Ki-67 Labeling Index and the Recognition of Apocrine-Type Lesions

BACKGROUND: Triple-negative breast cancer encompasses heterogeneous subtypes. Neoadjuvant chemotherapy is ineffective against some triple-negative breast cancers, while others show a favorable prognosis despite chemoresistance. METHODS: A total of 51 cases with stages I and II triple-negative breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubouchi, Koichi, Shimada, Kyosuke, Yokoe, Takamichi, Tsutsumi, Yutaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370551/
https://www.ncbi.nlm.nih.gov/pubmed/32677589
http://dx.doi.org/10.1177/1533033820943246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370551/
https://www.ncbi.nlm.nih.gov/pubmed/32677589
http://dx.doi.org/10.1177/1533033820943246

Ejemplares similares